Algo version: 0.98b
TARS is listed at the NASDAQ Exchange
TARS [TARS]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is TARS stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Tarsus Pharmaceuticals, 10 years ago, but if you had invested on Friday 16th of October 2020 when the price was $20.58, you would have made a profit of $10.04 per share or 48.79%

Yes, the average daily trading liquidity for Tarsus Pharmaceuticals, is $20.27 million. You should therefore be able to get in and out of your positions relatively fast.

Tarsus Pharmaceuticals, has little of the business financed by loans. This puts the company at lower risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Tarsus Pharmaceuticals, to be medium [0.7 out of 1]